facebook pixel

Claire FRASSE Europe Export Manager

Q: What were the main reasons in choosing SofMedica as a partner and when did it all start?
A: We first started working with SofMedica in January 2017. There are several reasons why we chose to collaborate with SofMedica – their expertise in robotic technology, vast experience in urology, impactful market presence and outstanding professionalism, amongst others.

Q: How was the relationship with SofMedica during these years?
A: Overall, it has been an enriching experience working with SofMedica these past two years. There have been some challenging moments along the way, mostly to do with changes in SofMedica’s team. However, SofMedica team’s professionalism has helped to overcome these difficulties.

Q: What are the qualities you appreciate in us as a partner?
A: Thoroughness, attention to detail, punctuality of follow-ups and project management.

Q: How do you see the future in the field of healthcare in our country?
A: Romania is a promising market with immense potential and capacity for development. We hope to take an active part in this development in the coming years.

Q: What is your message for us at this celebration anniversary?
A: Carry on the good work, continue with your commendable values and work ethic and above all, be relentless in your efforts to be the best in the market! Wishing you all the very best!

David Kearns Senior Director Export & EMEA Marketing

Conmed and SofMedica became partners in 2016 through the acquisition of SurgiQuest, it became quickly clear that we were working with a professional, ambitious company that already had a prestigious position in the markets they serve, supporting surgical innovation and ground breaking technology.

Conmed expanded the partnership to cover all active SofMedica markets and with the full Conmed General Surgery portfolio. Since our expanded collaboration, SofMedica has worked on establishing the Conmed laparoscopic portfolio as the partner of choice for stable pneumoperitoneum and development of true day surgery laparoscopy through our Low Impact initiative.

Through true collaboration, I see a very strong future for SofMedica and Conmed in the development of Minimally Invasive Surgery and am excited that better patient outcomes and faster recovery from surgery will have a true lower impact on all aspects of health care across Greece, Romania and Bulgaria.

Congratulation to the whole SofMedica team for achieving this significant milestone anniversary, there are many great achievements still be come.

Kieron O’Neil Senior Director
Global Sales & Marketing – Acute

“Nikkiso have been collaborating with SofMedica since the acquisition of the CRRT business in 2014. Although, I also previously supported the Sofmedica team during the early days of the Aquarius machine, when the business was owned by Edwards Lifescience.

CRRT is a complex life-saving therapy which, due to its potentially in-frequent use by a critical care nurse, requires a significant amount of continuous education and training for the customer. For any partner of Nikkiso CRRT, it is essential this ethos is integral to a shared business vision. Through the many years associated with Aquarius and this therapy area, SofMedica have consistently demonstrated a commitment with focus on the growth of our mutual business, and education of clinicians and nursing staff about CRRT. This culminating in the launch of citrate-based therapies over the last 12 months, the next phase for innovative CRRT in Romania.

The entire team of Nikkiso (CRRT), consider the SofMedica team to be a truly professional, reliable and responsive partner, and look forward to a future strong market performance in Romania and the launch of our next generation of CRRT products.

On behalf of Nikkiso CRRT, congratulations on reaching this milestone in your company history and sincere thanks for all you do to enhance patient care in your region.”

dr. Bogdan Busuioc Medic specialist gastroenterologie

Q: Domnule doctor Bogdan Busuioc, multumim pentru ca ati acceptat sa fiti primul Vizionar care ia parte la campania SofMedica „Vizionar in Romania”. Ce inseamna pentru dumneavoastra a fi vizionar?
A: In primul rand dati-mi voie sa va multumesc pentru invitatie. In ceea ce priveste intrebarea dumneavoastra, din punctul meu de vedere a fi vizionar inseamna a te lasa purtat de idealuri, a dori sa te autodepasesti, sa imbunatatesti ceea ce este in jurul tau, cu un viitor mai bun.

Q: Va considerati un vizionar? De ce?
A: Plecand de la cele de mai sus imi doresc sa cred ca indeplinesc aceste criterii; ca prin activitatea mea de fiecare zi tind catre acest ideal.

Q: Spuneti-ne cateva lucruri care va definesc ca om si ca medic.
A: Cred ca activitatea mea de zi cu zi, de a ameliora suferinta pacientilor, ma defineste atat ca medic cat si ca om.

Q: Care sunt cele mai importante afectiuni gastrointestinale?
A: Nu cred ca exista o patologie mai importanta decat alta, pentru fiecare pacient suferinta lui primeaza, insa specificul compartimentului nostru se adreseaza in special patologiei neoplazie fie diagnostic, fie terapeutic.

Q: Cat de importanta este preventia in specialitatea dumneavoastra?
A: Preventia sta la baza medicinii moderne. Cel putin 50% din cazurile care ajung in compartimentul nostru reprezinta evaluari de screening pentru patologie neoplazica.

Q: Cum va ajuta tehnologia in depistarea la timp a acestor afectiuni si cat de importanta este performanta echipamentelor?
A: O data cu dezvoltarea tehnologiei, a fost posibila depistarea unor leziuni in stadii incipiente, ceea ce a dus la scadere mortalitatii si morbiditatii. Cu cat echipamentele sunt mai evoluate cu atat putem depista leziuni mai mici ducand la interventii minim invazie in scop curativ.

Q: Sunteti unul dintre utilizatorii sistemului de endoscopie Fujifilm comercializat de SofMedica. Credeti ca performantele acestuia raspund nevoilor dumneavoastra si ale pacientilor de diagnostic corect in conditii de confort crescut?
A: Utilizand sistemele de endosocpie Fujifilm am reusit sa crestem semnificativ rata de detectie a adenoamelor (leziuni premaligne) in cadrul procedurilor de colonoscopie. In acelasi timp utilizarea sitemelor de duodenoscopie si ecoendoscopie a facut ca pacientii cu stadii avansate de neoplazii pancreatice si biliare sa beneficieze de tratament modern cu scadere semnificativa a morbiditatii si cresterea supravietuirii.

Q: Cum apreciati legatura cu specialistii SofMedica?
A: Am o legatura stransa cu colegii din SofMedica, acestia mi-au oferit mereu suportul necesar pentru dezvoltare.